XNYS
GMREpA
Market cap456mUSD
Oct 08, Last price
24.42USD
1D
-0.53%
1Q
-1.69%
IPO
-1.21%
Name
Global Medical REIT Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
Related entities
Subsidiaries
GLOBAL MEDICAL REIT L.P.
Key people
Danica Holley
Chief Operating Officer · since 2016
Alfonzo Leon
Chief Investment Officer · since 2015
Allen Webb
Executive Officer · since 2016
Jamie Barber
General Counsel, Secretary · since 2017
Chairman of the Board, President, Chief Executive Officer · since 2017
Jingguo Zhang
Director · since 2015
Lead Independent Director · since 2017
Paula Crowley
Independent Director · since 2018
Ronald Marston
Independent Director · since 2015
Independent Director · since 2015
Lori Beth Wittman
Independent Director · since 2018
Legal address
c/o THE CORPORATION TRUST INCORPORATED; 2405 YORK ROAD SUITE 201
LUTHERVILLE TIMONIUM, MD 21093
US
LUTHERVILLE TIMONIUM, MD 21093
US
Headquarters
2 Bethesda Metro Center, Suite 440
Bethesda, MD 20814
US
Bethesda, MD 20814
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||